Literature DB >> 4118822

Oxprenolol in thyrotoxicosis.

M G Gibberd, J S Staffurth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4118822     DOI: 10.1016/s0140-6736(73)90038-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Adrenergic beta-receptor blockade in hyperthyroidism.

Authors:  I Ramsay
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

Review 2.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 4.  Formulary considerations in selection of beta-blockers.

Authors:  K C Yedinak
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

5.  Long-term therapy of essential tremor with propranolol.

Authors:  T J Murray
Journal:  Can Med Assoc J       Date:  1976-11-06       Impact factor: 8.262

6.  Comparative trial of propranolol and practolol in hyperthyroidism.

Authors:  J K Nelson; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

7.  Comparison of propranolol and practolol in the management of hyperthyroidism.

Authors:  L E Murchison; P D Bewsher; M I Chesters; W R Ferrier
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.